TABLE 5.

(Adverse) maternal outcomes (intention‐to‐treat)

	Temporizing management	Immediate delivery	Relative risk (95% CI)	P value
	(n = 30)	(n = 25)
Eclampsia	0	0	n/a
Pulmonary edema	1 (3%)	0	n/a
Liver hematoma	0	0	n/a
HELLP syndrome	7 (23%)	9 (35%)	0.67 (0.29‐1.56)	.35
Hemolysis	0	1 (4%)	n/a
Low platelets b	3 (10%)	4 (16%)	0.65 (0.16‐2.64)	.69
Abnormal liver function tests c	7 (23%)	7 (27%)	0.87 (0.35‐2.15)	.76
Placental abruption	1 (3%)	0	n/a
Maternal death	0	0	n/a
Women with maternal complications a	9 (30%)	9 (36%)	0.83 (0.39‐1.78)	.64

^aMultiple inclusion criteria possible.

^b≤100.10³/mm³.

^cALAT ≥70 or ASAT ≥70 U/L.